Mrs. Nurun Nahar Karim is a renowned social worker & Chairman of BEACON Pharmaceuticals PLC. Nurun Nahar Karim is a Post Graduate from the University of Dhaka & holding director position of the following companies-

• BEACON Development Ltd
• Kohinoor Chemicals Co. (BD) Ltd
• BEACON Point Ltd.

Our employees are leaders and passionate about exploring new ways to address health challenges.

The young business entrepreneur Niazul Karim is a business graduate & member of Board of Directors of all the Group of companies. Mr. Niaz is leading the team in diversification of business. He is holding the following position-

• Vice Chairman of Beacon Pharmaceuticals PLC 
• Director of Beacon Development Ltd
• Managing Director of BEACON Point Ltd.

Everything we do is for the betterment of Patients.

Mr. Ulfat Karim is the Managing Director of Beacon Pharmaceuticals PLC, bringing dynamic leadership, strategic vision, and a strong commitment to operational excellence. A forward-thinking and results-driven entrepreneur, he represents a new generation of corporate leadership focused on innovation, efficiency, and sustainable growth.

Mr. Karim began his professional journey with Beacon Pharmaceuticals PLC, one of Bangladesh’s leading pharmaceutical companies, where he served as Executive Director from 9 August 2021 to 9 August 2023. In recognition of his exceptional performance, strategic insight, and leadership capabilities, he was appointed Director and Chief Operating Officer (COO) effective 10 August 2023. His successful tenure as COO culminated in his appointment as Managing Director, reflecting the Board’s confidence in his ability to steer the company toward long-term success.

As COO, Mr. Karim played a pivotal role in transforming Beacon’s operational landscape. He spearheaded comprehensive cost-control initiatives across production, supply chain, and procurement functions, resulting in a significant reduction in operating costs while maintaining stringent quality standards and full compliance with international regulatory requirements. His focus on lean operations and data-driven decision-making strengthened financial discipline and substantially increased net profit after tax.

Under his leadership, Beacon Pharmaceuticals achieved consistent double-digit year-on-year revenue growth through strategic product diversification, expansion into new export markets, and the modernization of marketing and commercial strategies. These initiatives significantly enhanced the company’s competitive position in both domestic and international markets.

Mr. Karim is also widely recognized for fostering a culture of accountability, collaboration, and continuous learning across the organization. He has empowered young professionals to take ownership of their responsibilities, encouraging innovation and high performance at every level of the company.

As Managing Director, Mr. Ulfat Karim continues to exemplify a powerful blend of youthful energy, modern business acumen, and a deep commitment to operational excellence. His leadership remains instrumental in driving Beacon Pharmaceuticals PLC and its affiliated ventures toward sustainable growth, global competitiveness, and long-term value creation.

“Our focus is on building a future-ready organization through innovation, operational excellence, and disciplined growth—ensuring sustainable value for all stakeholders.”

She undertook the responsibility as Executive Director of BEACON Pharmaceuticals PLC, demonstrated her entrepreneurial skills and experience to establish durable position notably in pharmaceutical sectors. She has completed her graduation in pharmacy from North South University.

With her dynamic leadership, she has been able to bring in a remarkable transformation in the operations of Beacon Group. She believes that operational excellence can be achieved through an integrated approach, engaging all stakeholders.

She believes in empowering a diversified workforce to reap the benefits of innovation. This has been reflected by the women empowerment in Beacon group.

She frequently travels to countries in Asia, Europe and Africa for business meetings and conferences. Being one of the Executive Director of the Beacon group, she enthusiastically undertakes social works:

Professor ABM Faroque has joined Beacon Pharmaceuticals PLC as an Independent Director in 2024. Professor ABM Faroque is an accredited and acknowledged researcher in the field of pharmaceutical technology and he has both national & international publications in the field of Pharmaceutical Industry. Currently, he is also serving as a Dean, School of Science and Engineering, Southeast University.

Professor ABM Faroque has a wide variety of knowledge in the Pharmaceutical Technology for more than 45 years of service in different position at Dhaka University and in different national & internal committee of the Government of Bangladesh. He was the Dean & Chairman of both Dept. of Pharmaceutical Technology & Dept of Pharmacy and also the Director of Biomedical Research Centre, Faculty of Pharmacy, University of Dhaka.

He has been nominated and assigned in different government body and associated with international organization over his long period of service. He was Convener, National Drug Policy Formulation Sub-Committee, Directorate General of Drug Administration, Ministry of Health & Family Welfare, Government of Bangladesh and Team Leader, Specialist Team for the inspection of all Pharmaceutical Companies of Bangladesh. He was Member, Herbal National Formulary Committee, WHO and Board of Unani & Ayurvedic Systems of Medicines, Ministry of Health & Family Welfare, Government of Bangladesh and Resource Person, Bangladesh Arsenic Mitigation & Safe Water Supplies Program, Directorate of Public Health Engineering, Ministry of Local Government and Rural Development, Government of Bangladesh.

He was also the member, Unani and Ayurvedic National Formulary Committee, WHO and Board of Unani & Ayurvedic Systems of Medicines, Ministry of Health & Family Welfare, Government of Bangladesh,1987-2000 and Member, National consultative committee on code of Marketing of Breast-Milk substitutes, Ministry of Health & Family Welfare, Government of Bangladesh. He was the dignitary resource person for UNICEF and WHO on different projects like Program on Control of lodine Deficiency Disorders in Bangladesh, universal lodization of salt, in Policy paper for children, Joint Government and UNICEF Action Group (JGUAG), prevention of Vitamin A and lodine Deficiencies in Bangladesh, TRIPS and Access to medicines in the least-Developed countries and WHO Essential Drug Program.

He has participated in many trainings and attendant a lot of seminars internationally. In his new role, Professor ABM Faroque will lead our efforts in enhancing excellence in pharmaceuticals industry internationally.

Mr. Rezanur Chowdhury has been qualified as a Chartered Accountant from the Institute of Chartered Accountant of Bangladesh in the year 1983. He has served in different companies in home and abroad, including British-American Tobacco Co. Ltd., Bangladesh and Anchor Electronics Sdn. Bhd. Malaysia.

Mr. Chowdhury has a wide variety of knowledge in the Accounting and Finance Sector for around 43 years of service in different position and in different companies. He has participated in many trainings and attendant a lot of seminars internationally.

Before joining Beacon Pharmaceuticals PLC he was engaged in Finance & Tax consultancy with reputation.

Qualifications:

Fellow member (FCA) of the Institute of Chartered Accountants of Bangladesh

Associate member (ACA) of the Institute of Chartered Accountants in England & Wales

Member of the institute of Internal Auditors of Bangladesh

BBA & MBA in Finance, University of Chittagong, Bangladesh.

Professional experiences include

With more than 15 years of experience in statutory audit, bookkeeping, tax compliance, statutory reporting and payroll. In his role as engagement leader, he constantly overseas the client operations and ensures timely reporting & statutory compliances. While ensuring the team is up to date with all the statutory changes, he coaches / trains the team on an ongoing basis to enable quality deliverables to the client.

Arif led Accounting Compliances & Reporting (ACR) and Business Consulting service line in EY Bangladesh. His service line mainly focuses on accounting services including FS preparation, tax provision & deferred tax calculation in accordance with IFRS and Bangladesh law, Internal audit outscored and co-sourced services which includes effective SOP design and implementations. Also experienced in statutory audit services.

Arif has extensive experience in consulting on development of accounting policies and procedures closely adjusted to IFRS; conversion of the local GAAP and applicable laws.

Ariful’s notable client credentials (Audit, ACR & Business Consulting) in Bangladesh are Bata Bangladesh, Unilever, Cisco Technologies; F5 Networks; Nokia Solutions & Networks Bangladesh; Société Internationale de Télécommunications Aéronautiques SCRL; Mondelez Bangladesh; Honeywell; Evonik Bangladesh, Microsoft Bangladesh; ABB Turbocharging, Aggrekko power, BBC, Ekaterra B.V, Magaldi Power, Sinohydro, Roche, Robi Axiata, Paxar, SIKA, UPS; etc to name a few.

In addition to his professional engagements, Arif actively contributes to the field by serving as an examiner for professional exams and participating as a trainer in various forums. His dedication and expertise make him a valuable asset in the domain of accountancy, assurance, and business advisory.

Professor Dr. Shamem Ara Mili has joined Beacon Pharmaceuticals PLC as an Independent Director in 2025. She is working as a Professor in the Department of Accounting and Information Systems at Comilla University, Bangladesh as well. She has also served as the Director of MBA (Evening) Program in the same Department. Dr. Mili has achieved PhD Degree from Universiti Sains Malaysia, Malaysia, with a focus on corporate governance, human capital management disclosure, firm value, and financial reporting timeliness of the listed companies in Bangladesh. She has also achieved an MPhil Degree from Islamic University, Bangladesh, with a focus on corporate social performance of the listed pharmaceutical companies in Bangladesh.

Dr. Mili has completed MBA and BBA (Hon’s) from the Department of Accounting and Information Systems of Rajshahi University, Bangladesh. She has achieved Taposhi Rabeya Hall Gold Medal for outstanding academic achievement in BBA (Hon’s). Dr. Mili has participated in several international conferences, and published a number of papers in internationally reputed Journals. She has been committed to making a bridge between academic knowledge and corporate practices, as well as committed to contributing to corporate governance, ESG, human capital management and business innovation practices in the corporate sectors of Bangladesh.

Md. Jalal Uddin FCA is a distinguished finance professional with over 15 years of progressive leadership experience in top-tier corporate and professional services environments. A Fellow Member of the Institute of Chartered Accountants of Bangladesh (ICAB), he joined Beacon Pharmaceuticals PLC in April 2022 as Head of Internal Audit. Demonstrating exceptional strategic and financial acumen, he was appointed Chief Financial Officer in May 2023 and subsequently assumed the additional responsibility of Head of IT in January 2024.

In his dual capacity, Mr. Uddin has been instrumental in strengthening Beacon's financial governance and driving its digital transformation agenda. A strong advocate for integrating finance with technology, Mr. Uddin spearheaded the Rise with SAP S/4HANA and ARIBA implementation across Beacon Pharmaceuticals PLC, Beacon Cephalosporin Ltd., and EREBA Capsules Ltd., modernizing financial management and reinforcing data-driven decision-making, an initiative that earned the Group the SAP ACE Award 2024 in the Game Changer category.

Prior to Beacon Group, he held progressively senior roles at Robi Axiata Limited over nearly seven years, including General Manager - Financial Governance, Compliance, Ethics & Integrity and General Manager - Financial Process & Control, leading corporate policy development, financial governance, and process automation, and playing a key role in finance integration during the Robi-Airtel merger. He began his career at A. Qasem & Co., Chartered Accountants, in audit and assurance.

A firm believer in the integration of finance and technology, Mr. Uddin has a proven track record in developing robust policies, control frameworks, and authority matrices while driving process simplification, automation, and digitalization within complex business environments. His visionary leadership continues to position Beacon Pharmaceuticals PLC as a front-runner in financial excellence and technological advancement within the pharmaceutical industry.

Miss Rahamat Ara Huda FCA, FCMA is an accounting professional having more than 15 years’ experience in the field of accounts & finance, strategic planning &budgeting, project & product feasibility analysis, cost management, budget and polices, cost-volume profit analysis, product pricing, financial accounting Plans, fund management, financial operation management, capital budgeting, TAX and VAT management, financial report preparation, financial & other regulatory reporting, internal audit and risk based auditing management. Miss Rahamat Ara Huda FCA, FCMA is playing as Head of Internal Audit at Beacon Pharmaceuticals PLC. As a Chartered Accountant & Cost and Management Accountant she has diversified working experiences in senior leadership position of different organizations.

Miss Rahamat Ara Huda FCA, FCMA has started her career at Anwar Group of Industries. Later she joined Maheen Dizayn Etiket (BD.) Limited and Maheen Label Tex Limited (sister concern of Impress group). Miss Rahamat Ara Huda FCA, FCMA worked Maheen Dizayn Etiket (BD.) Limited and Maheen Label Tex Limited for more than seven years as Departmental Head of Internal Audit, Head of Accounts & Finance and General Manager (Accounts & Finance). Before joined Beacon Pharmaceuticals PLC she worked at Walton Hi- Tech Industries PLC as Deputy & Acting Head of Internal Audit & Compliance. She has completed CA articleship from UHY Syful Shamsul Alam & Co. one of leading Chartered accounting firm in Bangladesh. Miss Rahamat Ara Huda FCA, FCMA is a member of Cost Audit Standard Committee of ICMAB for the year 2025. Miss Rahamat Ara Huda FCA, FCMA is engaged with various professional and social groups and work for development of accounting profession and society.

Mr. Anindya Sarkar is a Fellow Member (FCS) of the Institute of Chartered Secretaries of Bangladesh (ICSB). He holds a Master of Business Administration (MBA) in Finance & Accounting and a Bachelor of Laws (LL.B.), a two-year professional law degree. He subsequently obtained the Chartered Secretary professional degree from the Institute of Chartered Secretaries of Bangladesh (ICSB).

With 18 years of professional experience, Mr. Sarkar has embraced diverse cross-functional assignments, enabling him to develop extensive expertise across a broad range of areas, including corporate affairs, finance, audit, human resources, banking, share management, and records management.

In addition to his responsibilities as Company Secretary, he serves as the Secretary to the Board Audit Committee, NRC Committee, and CSR and Sustainability Committee of the Company. His broad-based professional experience and multidisciplinary expertise contribute significantly to effective corporate governance, compliance, and organizational management.

Qualification: M.Sc (Chemistry), MBA (HRM)

He is trained Human Resources Management (USA), Solving Human & Organizational Problems (Japan) and Train the Trainer (UK & Singapore).

Past Experience: Prior to this, he served in Orion Pharma Limited

Our employees are our greatest asset.

Md. Jalal Uddin is a fellow member of the Institute of Chartered Accountants of Bangladesh and Master of Business Administration. He joined Beacon Pharmaceutical PLC in April 2022 having more than 13 years of experiences in reputed corporates and professional services firm. Prior to joining Beacon Pharma, he was the head of financial governance, compliance, ethics, and integrity in Robi Axiata Limited.

He possesses diversified skills and experience in financial management, reporting, taxation, compliance testing, auditing, and assurance services. He is highly qualified and experienced in designing policies, procedures, limits of authority and an expert in process simplification, automation, and digitalization for large and complex operations.